11-08-2026 16:05 via drugs.com

Real-World Performance Of Alzheimer's Drug Matches Trial Data, Study Finds

TUESDAY, Aug. 11, 2026— Sally Osmer jumped at the chance to be treated with the cutting-edge Alzheimer’s drug lecanemab.Osmer has a family history of the disease, and was diagnosed with early-stage Alzheimer’s at age 74. She didn’t notice any...
Read more »

Pharmaceutical news



Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
Socioeconomic Inequalities Tied to Functional Aging
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
Study IDs Neurobiological Roots of Sensory Over-Responsivity
2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening
Rare Bacteria In Coastal Waters Has Killed 7 This Summer
Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes
Older Adults Limit Movements With Rising Temperatures
Therapeutic Hypothermia Duration Explored in Comatose OHCA Survivors
Socializing: A Prescription For Healthier Brain Aging
Taking The Stairs May Lower Your Risk Of Dying From Heart Disease
Sweet Tooth? It Could Be Shaping Your Decisions, Study Says
Desktop versie